Martijn Kleijwegt serves as Executive at Eloxx Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Martijn Kleijwegt has executed 1 insider transactions totaling $2.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 30, 2018 involved purchasing 300,000 shares valued at $2.9M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 30, 2018 | ELOX | $2.9M | Purchase | 300,000 | $9.75 | Discretionary |
Martijn Kleijwegt currently holds 2,953,673 shares of Eloxx Pharmaceuticals, Inc. (ELOX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martijn Kleijwegt has been a net buyer of ELOX stock. They have purchased $2.9M and sold $0 worth of shares.
Martijn Kleijwegt's most recent insider trade was on Apr 30, 2018, when they purchased 300,000 shares at $9.75 per share.
Get notified when new Form 4 filings are submitted